Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements
July 7th, 2025
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Category: Investors
Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward
June 17th, 2025
Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3’25 Financial Results Report in Mid-August
June 16th, 2025
Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17
May 29th, 2025
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025
May 29th, 2025
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
April 8th, 2025
Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025
March 12th, 2025
APDN Reminds Shareholders to Vote Ahead of Special Meeting on February 14
February 11th, 2025
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
January 8th, 2025